Ocular rosacea drug (MC2 Therapeutics)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameOcular rosacea drug (MC2 Therapeutics)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsRosaceaEye Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryDenmark
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMc2 Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMc2 Therapeutics Ltd
Active IndicationsN/A
Inactive IndicationsRosaceaEye Diseases

Other Information

ATC CodeN/A
Related LinksN/A